London
· Delayed Price · Currency is GBP · Price in GBXIXICO Company Description
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.
Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study.
The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer.
In addition, the company focuses in therapeutic areas include Alzheimer's, Parkinson’s, Huntington’s, Multiple Sclerosis, and orphan and rare diseases.
Further, the company engages in the data collection and analysis of neurological disorders. Additionally, it offers drug development analytics, imaging operation, post marketing surveillance, and consultancy services; and end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway.
IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.
| Country | United Kingdom |
| Founded | 1995 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 89 |
| CEO | Bram Goorden |
Contact Details
Address: Griffin Court London, EC1A 9PN United Kingdom | |
| Phone | 44 20 3763 7499 |
| Website | ixico.com |
Stock Details
| Ticker Symbol | IXI |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | October - September |
| Reporting Currency | GBP |
| ISIN Number | GB00BFXR4C20 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Bram Goorden | Chief Executive Officer |
| Grant Nash | Chief Financial Officer |